Disease Therapies and Diagnostics I

Thursday, November 20, 2008: 8:30 AM
303-A (Pennsylvania Convention Center)

Description:
Molecular and cellular science and engineering efforts over the past decade have given rise to numerous novel approaches for detecting and treating disease. These approaches have substantial potential for early detection and to provide highly specific and efficacious therapies for challenging disease targets (e.g. persistent pathogen infections, neurodegenerative disease and cancer). This session will highlight these creative approaches, including but not limited to biosensors, combination drug therapies, novel drug delivery systems (e.g. mechanisms to cross the blood-brain barrier), catalytic (e.g. proteolytic) therapies, nanotherapies, nucleic acid and RNA interference therapies, gene therapies, oncolytic viruses, cell and stem cell based therapies. Both discovery and development efforts, including therapeutic design approaches based on systems-level modeling, will be covered. Furthermore, translation of these ‘next generation’ therapeutics for the detection and treatment of specific disease targets will be emphasized.


Sponsor:
Engineering Fundamentals in Life Science


Chair:
Sundararajan V. Madihally
Email: sundar.madihally@okstate.edu

CoChair:
Christa N. Hestekin
Email: christa.hestekin@uark.edu


8:30 AM
(587a) In Vivo Monitoring of Viral Proteolytic Activity Using Luminescent Quantum Dot FRET-Based Probes
Divya Sivaraman, Marylynn V. Yates, Ashok Mulchandani and Wilfred Chen

9:10 AM
(587c) Engineered Knottin Polypeptides. A New Class of In Vivo Molecular Imaging Agents
Richard H. Kimura, Aron M. Levin, Zhen Cheng, Sanjiv Sam Gambhir and Jennifer R. Cochran

9:50 AM

10:20 AM
(587f) Engineering of Embryonic Stem Cell Neurogenic Differentiation for Neurodegenerative Diseases
Daniel E. Kehoe, Ewa K. Stachowiak, Michal K. Stachowiak and Emmanuel (Manolis) S. Tzanakakis

10:40 AM
(587g) Optimization of An Enrichment Process for Circulating Tumor Cells from the Blood of Head and Neck Cancer Patients through Depletion of Normal Cells
Liying Yang, James, Campbell Lang, Priya Balasubramanian, David Schuller, Amit Agrawal, Maciej Zborowski and Jeffrey J. Chalmers
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division